Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Identification of key microRNAs in the carotid arteries of ApoE -/- mice exposed to disturbed flow.

Tytuł:
Identification of key microRNAs in the carotid arteries of ApoE mice exposed to disturbed flow.
Autorzy:
Wang X; 1Laboratory of Cell Imaging, Henan University of Chinese Medicine, 6 Dongfeng Rd, Zhengzhou, 450002 Henan China.
Gao S; 1Laboratory of Cell Imaging, Henan University of Chinese Medicine, 6 Dongfeng Rd, Zhengzhou, 450002 Henan China.
Dai L; 2School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046 China.
Wang Z; 3Institute of Cardiovascular Disease, Henan University of Chinese Medicine, Zhengzhou, 450002 China.
Wu H; 1Laboratory of Cell Imaging, Henan University of Chinese Medicine, 6 Dongfeng Rd, Zhengzhou, 450002 Henan China.; 3Institute of Cardiovascular Disease, Henan University of Chinese Medicine, Zhengzhou, 450002 China.
Źródło:
Hereditas [Hereditas] 2019 Nov 05; Vol. 156, pp. 35. Date of Electronic Publication: 2019 Nov 05 (Print Publication: 2019).
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: Oct. 2015- : London : BioMed Central Ltd.
Original Publication: Lund : Mendelska sällskapet.
MeSH Terms:
Blood Flow Velocity*
Carotid Arteries/*metabolism
Carotid Arteries/*physiopathology
MicroRNAs/*genetics
Animals ; Atherosclerosis/etiology ; Atherosclerosis/metabolism ; Atherosclerosis/physiopathology ; Computational Biology/methods ; Disease Susceptibility ; Gene Expression Profiling ; Gene Ontology ; Gene Regulatory Networks ; Mice ; Mice, Knockout, ApoE ; Protein Interaction Mapping ; Protein Interaction Maps ; Regional Blood Flow ; Shear Strength ; Signal Transduction ; Transcriptome
References:
PLoS One. 2019 Mar 15;14(3):e0213494. (PMID: 30875406)
Circ Res. 2016 Feb 19;118(4):679-91. (PMID: 26892966)
PLoS One. 2015 Mar 20;10(3):e0120586. (PMID: 25793984)
J Intern Med. 2016 Jul;280(1):114-28. (PMID: 26791914)
Circ Res. 2016 Feb 19;118(4):703-20. (PMID: 26892968)
Genes (Basel). 2019 Jan 21;10(1):. (PMID: 30669689)
Microcirculation. 2015 Nov;22(8):700-10. (PMID: 26214161)
J Hum Hypertens. 2014 Apr;28(4):251-8. (PMID: 24152824)
Ann Hepatol. 2017 Oct 28;16(Suppl. 1: s3-105.):s27-s42. (PMID: 29080338)
Circ Res. 2016 Feb 19;118(4):692-702. (PMID: 26892967)
Can J Cardiol. 2017 Mar;33(3):313-324. (PMID: 28232017)
Semin Liver Dis. 2015 Feb;35(1):3-11. (PMID: 25632930)
Atherosclerosis. 2007 Oct;194(2):e26-33. (PMID: 17214991)
Circ Res. 2013 Apr 12;112(8):1150-8. (PMID: 23476055)
Clin Exp Pharmacol Physiol. 2017 Jul;44(7):711-718. (PMID: 28440887)
Blood. 2010 Oct 14;116(15):e66-73. (PMID: 20551377)
Br J Pharmacol. 2017 Jan;174(1):101-115. (PMID: 27774624)
Circ Res. 2019 Feb 15;124(4):467-469. (PMID: 30763209)
Microcirculation. 2011 Feb;18(2):102-17. (PMID: 21166929)
Nat Cell Biol. 2012 Feb 12;14(3):249-56. (PMID: 22327366)
Circulation. 2008 Aug 5;118(6):658-66. (PMID: 18645058)
Ann Med. 2009;41(1):19-28. (PMID: 18608132)
Eur Heart J Cardiovasc Imaging. 2017 Jan;18(1):19-30. (PMID: 27013245)
PLoS One. 2017 Nov 30;12(11):e0189088. (PMID: 29190756)
Cancers (Basel). 2019 Mar 07;11(3):null. (PMID: 30866509)
Nature. 2016 Jan 14;529(7585):216-20. (PMID: 26735015)
Trends Mol Med. 2015 May;21(5):307-18. (PMID: 25771097)
Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H496-504. (PMID: 24363303)
Biochem Biophys Res Commun. 2017 Apr 22;486(1):29-35. (PMID: 28223216)
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2206-16. (PMID: 25012134)
Int Immunopharmacol. 2018 Feb;55:69-76. (PMID: 29227823)
J Cell Sci. 2015 Jan 1;128(1):70-80. (PMID: 25395581)
Atherosclerosis. 2010 Nov;213(1):115-21. (PMID: 20864106)
Cell Metab. 2012 Mar 7;15(3):372-81. (PMID: 22405072)
Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):374-386. (PMID: 29074464)
Atherosclerosis. 2018 Mar;270:76-88. (PMID: 29407891)
Curr Opin Cardiol. 2016 May;31(3):249-54. (PMID: 26885771)
Circ J. 2011;75(3):703-9. (PMID: 21266788)
Cardiovasc Ther. 2016 Oct;34(5):308-13. (PMID: 27225585)
Transl Res. 2013 May;161(5):381-92. (PMID: 23274306)
JCI Insight. 2017 Feb 23;2(4):e91700. (PMID: 28239661)
Am J Physiol Heart Circ Physiol. 2014 Apr 15;306(8):H1192-203. (PMID: 24486510)
J Biomech. 1996 Apr;29(4):543-7. (PMID: 8964784)
Contributed Indexing:
Keywords: Atherosclerosis; Bioinformatics; Microarray analysis; Oscillatory blood flow; microRNA
Substance Nomenclature:
0 (MicroRNAs)
Entry Date(s):
Date Created: 20191114 Date Completed: 20200430 Latest Revision: 20220411
Update Code:
20240105
PubMed Central ID:
PMC6833270
DOI:
10.1186/s41065-019-0112-x
PMID:
31719822
Czasopismo naukowe
Background: Atherosclerosis (AS) is one of the main causes of cardiovascular disease. AS plaques often occur in blood vessels with oscillatory blood flow and their formation can be regulated by microRNAs (miRNAs). The aim of this study is to identify the key miRNAs and molecular pathways involved in this pathological process.
Methods: In this study, gene chip data obtained from the GEO database was analyzed using the LIMMA package to find differentially expressed miRNAs (DE miRNAs) in the carotid arteries of ApoE -/- mice exposed to different blood flow rates. Predicted targets of the DE miRNAs were identified using the TargetScan, miRDB, and DIANA databases respectively, and the potential target genes (PTGs) were found by analyzing the common results of three databases. The DAVID database was used to enrich the PTGs based on gene ontology (GO) and pathway (Kyoto Encyclopedia of Genes and Genomes, KEGG), and the STRING database was used to uncover any protein-protein interactions (PPI) of the PTGs.
Results: The networks of the DE miRNAs-PTGs, Pathway-PTGs-DE miRNAs, and PTGs PPI, were constructed using Cytoscape, and 11 up-regulated and 13 down-regulated DE miRNAs and 1479 PTGs were found. GO results showed that PTGs were significantly enriched in functions such as transcriptional regulation and DNA binding. KEGG results showed that PTGs were significantly enriched in inflammation-related mitogen-activated protein kinase (MAPK) and AS-related FOXO pathways. The PPI network revealed some key target genes in the PTGs.
Conclusions: The analysis of key miRNAs and molecular pathways that regulate the formation of AS plaques induced by oscillatory blood flow will provide new ideas for AS treatment.
Competing Interests: Competing interestsThe authors declare that they have no conflicts of interest.
(© The Author(s) 2019.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies